Changes in autologous HSCT rates from 1990 to 2000 in 9 selected countries with predictions for 2003
| . | Year of transplantation . | Maximum transplantation rate . | Predictions 2003 . | ||||
|---|---|---|---|---|---|---|---|
| 1990 . | 1995 . | 2000 . | Year . | Transplantation rate . | Transplantation rate . | r2 . | |
| Leukemias | |||||||
| Acute myeloid leukemia | 10.8 ± 2.2 | 19.3 ± 4.8 | 23.7 ± 4.4 | 1998 | 23.9 ± 4.0 | 24 | 0.968 |
| Acute lymphocytic leukemia | 8.1 ± 1.8 | 9.9 ± 2.6 | 6.2 ± 2.1 | 1991 | 10.0 ± 2.8 | 3 | 0.67 |
| Chronic myeloid leukemia | 2.4 ± 1.4 | 5.5 ± 1.5 | 3.6 ± 1.3 | 1998 | 8.1 ± 2.7 | (3.6)4-150 | 0.656 |
| Myelodysplastic syndromes | 0.1 ± 0.1 | 1.1 ± 1.3 | 1.4 ± 0.8 | 2000 | 1.4 ± 0.8 | 1.7 | 0.901 |
| Chronic lymphocytic leukemia | — | 1.3 ± 0.7 | 5.6 ± 1.5 | 2000 | 5.6 ± 1.5 | 11.2 | 0.933 |
| Lymphoproliferative disorders | |||||||
| Multiple myeloma | 3.8 ± 2.4 | 34.3 ± 12.1 | 82 ± 15.2 | 2000 | — | 121.6 | 0.99 |
| Hodgkin disease | 9.3 ± 2.7 | 21.9 ± 4.5 | 24.9 ± 3.2 | 2000 | — | 23.1 | 0.979 |
| Non-Hodgkin lymphoma | 13.7 ± 5.0 | 56.6 ± 8.4 | 95.5 ± 13.6 | 2000 | — | 118.9 | 0.986 |
| Solid tumors | |||||||
| Neuroblastoma | |||||||
| Glioma | 1.7 ± 1.6 | 1.6 ± 1.1 | 1.8 ± 0.9 | 2000 | — | 1.4 | 0.45 |
| Soft tissue sarcoma | 1.2 ± 0.6 | 2.0 ± 0.8 | 3.8 ± 1.1 | 1997 | 4.0 ± 1.3 | 3.98 | 0.882 |
| Germinal tumors | 3.6 ± 1.9 | 7.3 ± 2.5 | 7.3 ± 2.5 | 1997 | 8.9 ± 2.4 | 4.1 | 0.951 |
| Breast cancer | 27.0 ± 1.5 | 33.3 ± 14.4 | 20.0 ± 8.8 | 1997 | 66.3 ± 19.3 | 04-150 | 0.734 |
| Ewing sarcoma | 1.1 ± 0.7 | 3.0 ± 0.8 | 5.6 ± 2.0 | 2000 | — | 6.7 | 0.961 |
| Lung cancer | NA | NA | 1.4 ± 0.7 | 1999 | 2.3 ± 1.3 | 04-150 | 0.882 |
| Ovarian cancer | NA | NA | 2.7 ± 1.1 | 1998 | 5.0 ± 1.5 | 04-150 | 0.999 |
| Other solid tumors | NA | NA | 7.6 ± 1.9 | 2000 | — | 3.04 | 0.883 |
| . | Year of transplantation . | Maximum transplantation rate . | Predictions 2003 . | ||||
|---|---|---|---|---|---|---|---|
| 1990 . | 1995 . | 2000 . | Year . | Transplantation rate . | Transplantation rate . | r2 . | |
| Leukemias | |||||||
| Acute myeloid leukemia | 10.8 ± 2.2 | 19.3 ± 4.8 | 23.7 ± 4.4 | 1998 | 23.9 ± 4.0 | 24 | 0.968 |
| Acute lymphocytic leukemia | 8.1 ± 1.8 | 9.9 ± 2.6 | 6.2 ± 2.1 | 1991 | 10.0 ± 2.8 | 3 | 0.67 |
| Chronic myeloid leukemia | 2.4 ± 1.4 | 5.5 ± 1.5 | 3.6 ± 1.3 | 1998 | 8.1 ± 2.7 | (3.6)4-150 | 0.656 |
| Myelodysplastic syndromes | 0.1 ± 0.1 | 1.1 ± 1.3 | 1.4 ± 0.8 | 2000 | 1.4 ± 0.8 | 1.7 | 0.901 |
| Chronic lymphocytic leukemia | — | 1.3 ± 0.7 | 5.6 ± 1.5 | 2000 | 5.6 ± 1.5 | 11.2 | 0.933 |
| Lymphoproliferative disorders | |||||||
| Multiple myeloma | 3.8 ± 2.4 | 34.3 ± 12.1 | 82 ± 15.2 | 2000 | — | 121.6 | 0.99 |
| Hodgkin disease | 9.3 ± 2.7 | 21.9 ± 4.5 | 24.9 ± 3.2 | 2000 | — | 23.1 | 0.979 |
| Non-Hodgkin lymphoma | 13.7 ± 5.0 | 56.6 ± 8.4 | 95.5 ± 13.6 | 2000 | — | 118.9 | 0.986 |
| Solid tumors | |||||||
| Neuroblastoma | |||||||
| Glioma | 1.7 ± 1.6 | 1.6 ± 1.1 | 1.8 ± 0.9 | 2000 | — | 1.4 | 0.45 |
| Soft tissue sarcoma | 1.2 ± 0.6 | 2.0 ± 0.8 | 3.8 ± 1.1 | 1997 | 4.0 ± 1.3 | 3.98 | 0.882 |
| Germinal tumors | 3.6 ± 1.9 | 7.3 ± 2.5 | 7.3 ± 2.5 | 1997 | 8.9 ± 2.4 | 4.1 | 0.951 |
| Breast cancer | 27.0 ± 1.5 | 33.3 ± 14.4 | 20.0 ± 8.8 | 1997 | 66.3 ± 19.3 | 04-150 | 0.734 |
| Ewing sarcoma | 1.1 ± 0.7 | 3.0 ± 0.8 | 5.6 ± 2.0 | 2000 | — | 6.7 | 0.961 |
| Lung cancer | NA | NA | 1.4 ± 0.7 | 1999 | 2.3 ± 1.3 | 04-150 | 0.882 |
| Ovarian cancer | NA | NA | 2.7 ± 1.1 | 1998 | 5.0 ± 1.5 | 04-150 | 0.999 |
| Other solid tumors | NA | NA | 7.6 ± 1.9 | 2000 | — | 3.04 | 0.883 |
NA indicates not applicable. Numbers reflect weighted transplantation rates per 10 million inhabitants.
indicates limitations of mathematical model; see “Results.”